As Cathay Gen Bancorp (CATY) Share Price Declined, Shareholder Natixis Has Upped Position; Medicines Co (MDCO) Stake Maintained by Bridger Management Llc

January 14, 2018 - By Michael Collier

Natixis increased its stake in Cathay Gen Bancorp (CATY) by 158.38% based on its latest 2017Q3 regulatory filing with the SEC. Natixis bought 8,993 shares as the company’s stock declined 7.41% while stock markets rallied. The institutional investor held 14,671 shares of the major banks company at the end of 2017Q3, valued at $590,000, up from 5,678 at the end of the previous reported quarter. Natixis who had been investing in Cathay Gen Bancorp for a number of months, seems to be bullish on the $3.61B market cap company. The stock increased 0.86% or $0.38 during the last trading session, reaching $44.7. About 286,077 shares traded. Cathay General Bancorp (NASDAQ:CATY) has risen 23.23% since January 14, 2017 and is uptrending. It has outperformed by 6.53% the S&P500.

Roberto Mignone increased its stake in Medicines Co (MDCO) by 14.13% based on its latest 2017Q3 regulatory filing with the SEC. Bridger Management Llc bought 347,714 shares as the company’s stock declined 20.30% while stock markets rallied. The hedge fund run by Roberto Mignone held 2.81 million shares of the major pharmaceuticals company at the end of 2017Q3, valued at $104.04M, up from 2.46 million at the end of the previous reported quarter. Bridger Management Llc who had been investing in Medicines Co for a number of months, seems to be bullish on the $1.98 billion market cap company. The stock increased 0.07% or $0.02 during the last trading session, reaching $27.51. About 750,600 shares traded. The Medicines Company (NASDAQ:MDCO) has risen 16.70% since January 14, 2017 and is uptrending. It has by 0.00% the S&P500.

Bridger Management Llc, which manages about $3.11 billion and $1.67 billion US Long portfolio, decreased its stake in Impax Laboratories Inc (NASDAQ:IPXL) by 738,687 shares to 602,456 shares, valued at $12.23M in 2017Q3, according to the filing. It also reduced its holding in Facebook Inc (NASDAQ:FB) by 95,177 shares in the quarter, leaving it with 226,328 shares, and cut its stake in Incyte Corp (NASDAQ:INCY).

Since December 7, 2017, it had 1 insider purchase, and 1 sale for $1.60 million activity. 136,250 shares were sold by MEANWELL CLIVE, worth $3.71M.

Investors sentiment decreased to 0.78 in Q3 2017. Its down 0.44, from 1.22 in 2017Q2. It worsened, as 32 investors sold MDCO shares while 64 reduced holdings. 19 funds opened positions while 56 raised stakes. 85.15 million shares or 1.36% less from 86.33 million shares in 2017Q2 were reported. Comerica Financial Bank holds 0.01% or 67,837 shares. Grp Inc One Trading LP has 0.03% invested in The Medicines Company (NASDAQ:MDCO). Bnp Paribas Arbitrage Sa stated it has 34,329 shares. Profund Advsr Limited Com reported 13,204 shares or 0.02% of all its holdings. Teacher Retirement Of Texas has invested 0% in The Medicines Company (NASDAQ:MDCO). Old West Management Ltd Limited Liability Company has 0.17% invested in The Medicines Company (NASDAQ:MDCO). Northern Trust Corporation owns 904,138 shares for 0.01% of their portfolio. Hightower Advsrs Limited Co has 7,187 shares. Focused Wealth Mgmt stated it has 5,850 shares. Teachers Retirement Sys Of The State Of Kentucky reported 0.07% in The Medicines Company (NASDAQ:MDCO). Moreover, Bancorporation Of New York Mellon has 0.01% invested in The Medicines Company (NASDAQ:MDCO). University Of Notre Dame Du Lac stated it has 1.99% of its portfolio in The Medicines Company (NASDAQ:MDCO). Mason Street Advisors Limited Liability Com has invested 0.01% in The Medicines Company (NASDAQ:MDCO). 161,297 were reported by New York State Common Retirement Fund. Granahan Management Ma holds 32,948 shares or 0.1% of its portfolio.

Among 10 analysts covering The Medicines Co (NASDAQ:MDCO), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. The Medicines Co had 32 analyst reports since August 28, 2015 according to SRatingsIntel. Cowen & Co maintained it with “Buy” rating and $54.0 target in Tuesday, October 10 report. The rating was maintained by Oppenheimer on Thursday, August 10 with “Hold”. RBC Capital Markets maintained The Medicines Company (NASDAQ:MDCO) on Monday, August 31 with “Outperform” rating. On Wednesday, November 16 the stock rating was maintained by RBC Capital Markets with “Outperform”. Citigroup maintained The Medicines Company (NASDAQ:MDCO) on Monday, August 14 with “Neutral” rating. The stock has “Hold” rating by Oppenheimer on Monday, August 28. The rating was maintained by Jefferies on Tuesday, September 12 with “Buy”. The firm earned “Buy” rating on Saturday, August 29 by JP Morgan. The rating was maintained by RBC Capital Markets on Monday, November 16 with “Outperform”. H.C. Wainwright maintained the shares of MDCO in report on Tuesday, July 25 with “Buy” rating.

Natixis, which manages about $10.85B US Long portfolio, decreased its stake in Splunk Inc (NASDAQ:SPLK) by 24,190 shares to 38,154 shares, valued at $2.54 million in 2017Q3, according to the filing. It also reduced its holding in Colgate Palmolive Co (NYSE:CL) by 154,112 shares in the quarter, leaving it with 127,748 shares, and cut its stake in United Contl Hldgs Inc (NYSE:UAL).

Investors sentiment increased to 1.72 in 2017 Q3. Its up 0.29, from 1.43 in 2017Q2. It increased, as 17 investors sold CATY shares while 48 reduced holdings. 34 funds opened positions while 78 raised stakes. 53.66 million shares or 1.31% less from 54.37 million shares in 2017Q2 were reported. The Illinois-based Nuveen Asset Mgmt Ltd has invested 0.01% in Cathay General Bancorp (NASDAQ:CATY). Point72 Asia (Hong Kong) Ltd invested 0% of its portfolio in Cathay General Bancorp (NASDAQ:CATY). First Advsr Limited Partnership owns 193,239 shares. American Century Cos owns 459,019 shares. State Board Of Administration Of Florida Retirement stated it has 0.01% in Cathay General Bancorp (NASDAQ:CATY). Horizon Invest Service Lc owns 0.11% invested in Cathay General Bancorp (NASDAQ:CATY) for 6,607 shares. Nationwide Fund reported 187,188 shares. Profund Advsrs Limited Liability holds 0.02% or 11,393 shares in its portfolio. State Treasurer State Of Michigan invested in 28,600 shares. Qs Investors Ltd holds 0.02% or 58,510 shares in its portfolio. Us Bankshares De reported 428 shares. Meeder Asset has 0.01% invested in Cathay General Bancorp (NASDAQ:CATY) for 1,272 shares. Congress Asset Mgmt Ma holds 102,240 shares or 0.06% of its portfolio. Vanguard Group reported 6.64M shares. Dimensional Fund Advsrs Lp holds 0.07% or 3.83M shares.

Since December 11, 2017, it had 0 insider buys, and 1 insider sale for $2.12 million activity.

Among 10 analysts covering Cathay Bancorp (NASDAQ:CATY), 3 have Buy rating, 0 Sell and 7 Hold. Therefore 30% are positive. Cathay Bancorp had 24 analyst reports since July 22, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Friday, July 7 by BMO Capital Markets. Keefe Bruyette & Woods maintained the stock with “Hold” rating in Thursday, December 21 report. The stock has “Hold” rating by Keefe Bruyette & Woods on Monday, July 24. The firm earned “Outperform” rating on Friday, November 3 by BMO Capital Markets. The firm has “Outperform” rating by RBC Capital Markets given on Thursday, January 21. The company was maintained on Thursday, January 4 by Sandler O’Neill. As per Monday, July 10, the company rating was maintained by Piper Jaffray. PiperJaffray upgraded the shares of CATY in report on Thursday, February 2 to “Overweight” rating. Wood maintained Cathay General Bancorp (NASDAQ:CATY) on Monday, July 11 with “Market Perform” rating. The rating was maintained by SunTrust with “Hold” on Tuesday, November 28.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: